Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Mischo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Anticancer Research|October 4, 2011
Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1Anita Luethy, Frank Stenner, Corinne Lohri, et al.
Oncotarget|October 15, 2016
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patientsMagdalena Lukamowicz-Rajska, Christiane Mittmann, Michael Prummer, et al.
Swiss Medical Weekly|June 2, 2011
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experiencePanagiotis Samaras, Marcel Blickenstorfer, Sarah R Haile, et al.
Journal of Clinical Apheresis|March 23, 2016
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patientsJulia-Tatjana Maul, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Annals of Hematology|August 14, 2010
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastimPanagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, et al.
Oncology|November 17, 2010
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantationPanagiotis Samaras, Elefteri M Buset, Raffaele Daniele Siciliano, et al.
Swiss Medical Weekly|June 7, 2013
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantationPanagiotis Samaras, Dimitrios Zardavas, Ulf Petrausch, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 31, 2019
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastasesSimon Bernatz, Elena I Ilina, Kavi Devraj, et al.
Yeast (Chichester, England)|July 31, 2010
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responsesAndreas Wadle, Axel Mischo, Sabine Strahl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II StudyPanagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Anticancer Research|October 4, 2011
Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1Anita Luethy, Frank Stenner, Corinne Lohri, et al.
Oncotarget|October 15, 2016
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patientsMagdalena Lukamowicz-Rajska, Christiane Mittmann, Michael Prummer, et al.
Swiss Medical Weekly|June 2, 2011
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experiencePanagiotis Samaras, Marcel Blickenstorfer, Sarah R Haile, et al.
Journal of Clinical Apheresis|March 23, 2016
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patientsJulia-Tatjana Maul, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Annals of Hematology|August 14, 2010
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastimPanagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, et al.
Oncology|November 17, 2010
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantationPanagiotis Samaras, Elefteri M Buset, Raffaele Daniele Siciliano, et al.
Swiss Medical Weekly|June 7, 2013
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantationPanagiotis Samaras, Dimitrios Zardavas, Ulf Petrausch, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 31, 2019
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastasesSimon Bernatz, Elena I Ilina, Kavi Devraj, et al.
Yeast (Chichester, England)|July 31, 2010
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responsesAndreas Wadle, Axel Mischo, Sabine Strahl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II StudyPanagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
Pageof 3